Top Markets
Coin of the day
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
Rangering i aksjer #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Aksjekurs
$0.53499835
Markedsverdi
$40.24M
Endring (1 dag)
2.50%
Endring (1 år)
-58.07%
Land
JP
Handel Chordia Therapeutics Inc. (190A)

Kategori

Aksjeprishistorikk for Chordia Therapeutics Inc. (190A)
Høyeste sluttskurs: $0.53 den 2026-08-01

Laveste sluttskurs: $1.06 den 2024-06-01
Aksjeprishistorikk for Chordia Therapeutics Inc. fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 10.93%
2025 -61.05%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$546.54 38.59%
US
$1.04K 56.71%
NL
$120.74 -14.98%
AU
$138.98 416.85%
US
$761.87 7.04%
CH